Skip to main content
Clinical Trials/NCT00523484
NCT00523484
Completed
Not Applicable

An Observational Study to Assess Correlation Between Prostate Specific Antigen & Beck Anxiety Index in Prostate Cancer Patients Under Hormonal Therapy

AstraZeneca1 site in 1 country1,200 target enrollmentMay 2007
ConditionsProstate Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
AstraZeneca
Enrollment
1200
Locations
1
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

This study is an observational study to see whether anxiety level can be correlated with PSA level under the current practice in the patients of prostate cancer taking hormonal therapy. For assessment of anxiety level BAI(Beck Anxiety Inventory) will be used. The target population for this study is the patients of prostate cancer diagnosed previously and who are taking hormonal therapy with regular follow-up and PSA test. The follow-up duration will be total 6 months with interim visit at 3 month and final visit at 6 month.

Registry
clinicaltrials.gov
Start Date
May 2007
End Date
November 2008
Last Updated
16 years ago
Study Type
Observational
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Provision of written informed consent
  • Patients who take PSA test regularly
  • Observation suitable patients for PSA change according to hormonal treatment at least for 6months
  • Locally advanced or advanced prostate cancer patients who is suitable for hormonal therapy
  • Prostate Cancer Patients who has been taking one treatment among 3 hormonal therapies in below:
  • Bicalutamide Monotherapy : Bicalutamide 150mg/day
  • Goserelin 3.6mg/10.8mg
  • MAB(Maximal Androgen Blockade) :Bicalutamide 50mg + Goserelin 3.6/10.8mg

Exclusion Criteria

  • Prohibition use under permitted indication
  • Previous inclusion in the present study
  • Participation in a clinical study during the last 30 days

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials